Get Them Out! Self-Administered IV Antibiotics at Home The - - PowerPoint PPT Presentation

get them out
SMART_READER_LITE
LIVE PREVIEW

Get Them Out! Self-Administered IV Antibiotics at Home The - - PowerPoint PPT Presentation

Get Them Out! Self-Administered IV Antibiotics at Home The Importance of a Propensity Score Robert W. Haley, MD Division of Epidemiology University of Texas Southwestern Medical Center Dallas No Disclosures The Problem Every hospital has


slide-1
SLIDE 1

Get Them Out!

Self-Administered IV Antibiotics at Home

The Importance of a Propensity Score

Robert W. Haley, MD Division of Epidemiology University of Texas Southwestern Medical Center Dallas

No Disclosures

slide-2
SLIDE 2

The Problem

  • Every hospital has patients who require long-

term IV antimicrobial infusion.

– Staph septicemia – Bacterial endocarditis – Diabetic foot – Osteomyelitis

  • After the initial workup, the patients occupy a

hospital bed only to receive the infusion.

  • Insured or charity patients can be discharged

to receive infusions in an LTAC or home health nurse, but uninsured patients stay in hospital.

slide-3
SLIDE 3

Hospital days

42 3

Intensity

  • f services

Disadvantages of Long-term Antimicrobial Infusion in Hospital

Burden on safety-net hospitals Burden on patients

Risk of complications (e.g., infection)

slide-4
SLIDE 4

Definition of OPAT

  • Outpatient Parenteral Antimicrobial Therapy
  • Provision of IV antibiotic therapy in at least 2

doses on different days outside the hospital.

  • Goals

– Allow patients to complete treatment safely and effectively in the comfort of their home or another

  • utpatient site

– Avoid the inconveniences, complications, and expense of hospitalization

slide-5
SLIDE 5

Models of outpatient parenteral antimicrobial therapy (OPAT) delivery

Paladino J A , and Poretz D. CID 2010;51:S198-S208

slide-6
SLIDE 6

Definition of OPAT

  • Outpatient Parenteral Antimicrobial Therapy
  • Provision of IV antibiotic therapy in at least 2

doses on different days outside the hospital.

  • Goals

– Allow patients to complete treatment safely and effectively in the comfort of their home or another

  • utpatient site

– Avoid the inconveniences, complications, and expense

  • f hospitalization
  • But not available to patients without funding (e.g.,

private insurance, Medicare, Medicaid or other local funding option).

slide-7
SLIDE 7

Kavita Bhavan, MD

slide-8
SLIDE 8

“Let unfunded patients do it themselves”

S-OPAT

Self-Administered Outpatient Parenteral Antimicrobial Therapy

slide-9
SLIDE 9

S-OPAT Program

slide-10
SLIDE 10

Intervention

  • Developed program in 2009 as an alternative for

uninsured patients to complete long-term antibiotic therapy at home comparable to services received in traditional funded settings.

  • Patients undergo bedside teaching and competency

assessment prior to discharge from hospital.

  • Transitioned from the hospital into a dedicated post-

discharge OPAT clinic, and followed weekly by nurses for PICC line care and at fixed intervals by physicians to assess clinical response to therapy.

slide-11
SLIDE 11

Best Practice Methods

  • Dedicated multidisciplinary OPAT team: Physician,

Pharm D, Care Management, RN

  • Effective multilingual patient education material at

the appropriate level of health literacy and employ the “teach back method” for bedside teaching

  • Standardized core competency tool to test and

record patient’s ability to self-administer IV antibiotics

11

slide-12
SLIDE 12

Incorporating Patient Safety into Transition of Care

slide-13
SLIDE 13
slide-14
SLIDE 14

Coaching patients for successful outcomes

slide-15
SLIDE 15

Patient Education

slide-16
SLIDE 16

Best Practice Methods

Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C, Leong-Grotz K, Castro C, Bindman A. Closing the Loop Physician Communication With Diabetic Patients Who Have Low Health Literacy. Arch Intern Med/Vol 163, Jan 13, 2003

Teach-Back: Closing the Loop

slide-17
SLIDE 17

Testing for Competency

slide-18
SLIDE 18

Teaching Tools

slide-19
SLIDE 19

Specific Instructions

slide-20
SLIDE 20

Preparing Antibiotics

slide-21
SLIDE 21

Wire coat hanger

Infusion by Gravity

slide-22
SLIDE 22

Weekly Followup in S-OPAT Clinic

slide-23
SLIDE 23

Study to Evaluate S-OPAT Objective

Determine whether indigent, often poorly educated and mostly non-English-speaking patients can self-administer long-term IV antibiotics at home (S-OPAT) as safely and effectively as traditionally accepted models of

  • utpatient care by a healthcare practitioner

available to patients with funding (H-OPAT)

slide-24
SLIDE 24

Outcomes

  • Compared patients treated in S-OPAT with those

treated in H-OPAT on 2 outcomes

– 30-day readmission rate – 1-year mortality rate

  • Calculated total number of hospital bed days

avoided, as reflected by number of days a patient self-administered parenteral antibiotic therapy as an outpatient under the S-OPAT program

slide-25
SLIDE 25

Controlling for Selection Bias

  • An observational study (non-randomized)
  • Patients in the S-OPAT and H-OPAT groups differed
  • n several important measures.

– Healthcare funding (insurance, Medicare, Medicaid) – Language – Nationality and US citizenship – Educational level – Age

  • These differences created a strong potential

for selection bias in the outcome.

  • Must control for this in the analysis.
slide-26
SLIDE 26

Two Approaches in a Multivariable Logistic Regression Analysis

  • Enter Covariates into the multivariable analysis
  • Enter a Propensity Score into the multivariable

analysis

slide-27
SLIDE 27

Two Approaches in a Multivariable Logistic Regression Analysis

  • Enter Covariates into the multivariable analysis

– Age – Sex – Race – Country of origin – Source of payment – Education level – Income

  • Enter a Propensity Score into the multivariable

analysis

slide-28
SLIDE 28

Two Approaches in a Multivariable Logistic Regression Analysis

  • Enter Covariates into the multivariable analysis

– Age – Sex – Race – Country of origin – Source of payment – Education level – Income

  • Enter a Propensity Score into the multivariable

analysis

Covariates control confounding, but not necessarily selection bias.

slide-29
SLIDE 29

Two Approaches in a Multivariable Logistic Regression Analysis

  • Enter Covariates into the multivariable analysis

– Age – Sex – Race – Country of origin – Source of payment – Education level – Income

  • Enter a Propensity Score into the multivariable

analysis

Covariates control confounding, but not necessarily selection bias. A propensity score measures each patient’s propensity (probability) of receiving the treatment (S-OPAT) based on their characteristics.

slide-30
SLIDE 30
  • R. Haley, Epi for Clin Investigator

Propensity Score

  • Definition: An individual patient’s probability
  • f receiving the treatment conditional on

measured covariates.

– “How do you develop a propensity score?”

slide-31
SLIDE 31
  • R. Haley, Epi for Clin Investigator

Development of Propensity Score

– Instead of putting covariates into the main multivariable logistic regression model:

Outcome = Treatment Covar-1 Covar-2 . . . Covar-I (output is the odds ratio)

– Develop a logistic regression model of the treatment:

Treatment = Determinant-1 Determinant-2 . . . Determinant-I / pred=PS And output the probability of treatment conditional on the determinant

  • variables. This is the PS (a continuous variable = probability of

treatment)

– Within the strata of the PS, the probability of getting the treatment is the same.

slide-32
SLIDE 32

Development of Propensity Score

– Instead of putting covariates into the main multivariable logistic regression model:

Outcome = Treatment Covar-1 Covar-2 . . . Covar-I PS (output is the odds ratio)

– Develop a logistic regression model of the treatment:

Treatment = Determinant-1 Determinant-2 . . . Determinant-I / pred=PS And output the probability of treatment conditional on the determinant

  • variables. This is the PS (a continuous variable = probability of

treatment)

– Within the strata of the PS, the probability of getting the treatment is the same.

slide-33
SLIDE 33
  • R. Haley, Epi for Clin Investigator

4 Ways to Use the Propensity Score

  • PS Covariate Adjustment (most used):

– Introduce the PS into the multivariable logistic model of outcome as a new covariate.

  • PS Stratification:

– Stratify the outcome analysis on the PS.

  • PS Matching:

– Match

  • PS Weighting:

– Weight the multivariable logistic model of

  • utcome with the inverse PS.
slide-34
SLIDE 34
slide-35
SLIDE 35

Summary of Patient Selection

a Patients who were homeless, had a history of IV drug abuse, or were medically unstable b The eligibility criteria are given in the appendix of the paper.

a b

slide-36
SLIDE 36

Logistic Regression Model of S-OPAT vs H-OPAT to Develop the Propensity Score

Outcome variable is S-OPAT vs H-OPAT

slide-37
SLIDE 37

Multivariable Proportional Hazards Regression

Model of 30-day Readmission

Model 1 controls for confounding by entering covariates into the model.

slide-38
SLIDE 38

Multivariable Proportional Hazards Regression

Model of 30-day Readmission

Model 1 controls for confounding by entering covariates into the model. The OR of 0.59 indicates that S-OPAT had a 41% lower 30- day readmission rate than H-OPAT. % reduction = 1 - OR

1 – 0.59 = 41% reduction

slide-39
SLIDE 39

Multivariable Proportional Hazards Regression

Model of 30-day Readmission

Model 1 controls for confounding by entering covariates into the model. Model 2 also controls for selection bias by entering the propensity score into the model.

1 – 0.59 = 41% reduction

slide-40
SLIDE 40

Multivariable Proportional Hazards Regression

Model of 30-day Readmission

Model 1 controls for confounding by entering covariates into the model. Model 2 also controls for selection bias by entering the propensity score into the model.

1 – 0.59 = 41% reduction 1 – 0.53 = 47% reduction

slide-41
SLIDE 41

Multivariable Proportional Hazards

Regression Model of 1-Year Mortality

Model 1 controls for confounding by entering covariates into the model. Model 2 also controls for selection bias by entering the propensity score into the model.

1 – 0.94 = 6% reduction 1 – 0.86 = 14% reduction

slide-42
SLIDE 42

Multivariable Proportional Hazards

Regression Model of 1-Year Mortality

Model 1 controls for confounding by entering covariates into the model. Model 2 also controls for selection bias by entering the propensity score into the model.

slide-43
SLIDE 43

Readmissions During Infusion Period

Readmissions for reason: S-OPAT H-OPAT Related to IV infusion 21/944 ( 2.2%) 4/244 ( 1.8%) NS Unrelated 131/944 (13.9%) 49/244 (21.9%) NS

Reasons related to IV infusion 13 PICC line dysfunction 10 Underlying infection not improving 6 Renal or hepatic toxicity from antibiotic 4 Catheter-related bloodstream infection 1 Deep vein thrombosis

slide-44
SLIDE 44

Impact of the S-OPAT Program on the Hospital’s Inpatient Bed Utilization

*Before the S-OPAT clinic was started, all of these days would have been spent in the hospital just to receive antimicrobial infusions.

*

slide-45
SLIDE 45

30 day readmission 47% lower for “self-care” (S-OPAT) population vs pts receiving standard of care (H-OPAT)

27,666 inpatient days

avoided over 4 years

~ $40,000,000 saved

for hospital Improved resource utilization by freeing beds for acutely ill

slide-46
SLIDE 46

What do Patients Value ?

  • Ability to return to work earlier
  • Ability to care for dependents at

home

  • Avoid high cost of hospitalization
  • Ability to complete therapy safely in

the comfort of home environment with minimal interruption of daily life

slide-47
SLIDE 47

Patient-Centered Outcomes Survey

slide-48
SLIDE 48

Lessons Learned

  • S-OPAT model delivers safe and effective

care outside of the hospital setting.

  • A multi-disciplinary approach is critical to

the successful implementation of this transition of care model.

  • Systematic “teach-back” training and weekly

clinic followup important and cost-effective.

  • Prior Perception vs Patients’ Ability to self

administer IV therapy through program of patient engagement and empowerment

slide-49
SLIDE 49

Questions?